To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
Coombs
R
R
University of Washington, School of Medicine, Retrovirus Laboratory, Seattle, WA.
Cotton
D
D
Hammer
S
S
Saag
M
M
van der Horst
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006678:HIV / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D019259:Lamivudine; D010818:Practice Patterns, Physicians'; D012367:RNA, Viral / Q000097:blood; D016047:Zalcitabine / Q000008:administration & dosage / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine